ImmunoPrecise Antibodies (IPA)

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

COVID-19 stocks are flying as Raoul Pal goes live with a recession update

Today is a busy day at INK. At the close we are rebalancing the 50-stock INK Canadian Insider (CIN) Index. Over the past week we have been highlighting some of the new entrants and in the Friday morning report we highlighted newcomer Mullen Group ( MTL). There is obviously a lot of uncertainty about the economy's path due to COVID-19. However, there is some hope emerging among biotech stocks that maybe some treatments might be on the way. In particular, two stocks focusing on anti-body research that we featured in INK Chat are rallying Friday.

The big winner is Sorrento Therapeutics (SRNE) which is up more than 150% based on a Fox News story that the company is claiming to have an effective treatment. Nicholas Winton who writes the weekly INK CIN technical blog highlighted this stock in INK Chat on May 11th.

Subscribe to RSS - ImmunoPrecise Antibodies (IPA)